Condition
Dyslipidaemia clinical trials and research
As of November 12, 2026, Find a Trial lists 5 Dyslipidaemia clinical trials that are recruiting, at sites in 16 countries (most in Singapore (1), Malaysia (1), Thailand (1)). 1 was first registered in the last 30 days. By phase: Phase 1 (1). Every study is explained in plain English. Data from ClinicalTrials.gov and NIH RePORTER, updated November 12, 2026.
- 5Clinical trials
- 1New in 30 days
- 16Countries
Newest Dyslipidaemia clinical trials
| Study | Phase | Where | Status | Registered |
|---|---|---|---|---|
| High BMI and periodontitis in Thai adults under 60 | — | Bangkok, Ratchathewi | Recruiting | Oct 19, 2026 |
| New virtual care pathway for older adults with chronic diseases | — | Kuala Lumpur | Recruiting | Sep 25, 2026 |
| ECC4703 with Sulfasalazine and Pitavastatin in adults with NAFLD and dyslipidemia | Phase 1 | Melbourne, Victoria | Recruiting | Jul 24, 2026 |
| Telehealth program for weight management and related health issues | — | Singapore | Recruiting | Mar 21, 2025 |
| A registry for studying Non-Alcoholic Fatty Liver Disease in Europe | — | Antwerp and 36 other locations | Recruiting | Jun 22, 2020 |
All recruiting trials (5)
-
High BMI and periodontitis in Thai adults under 60
This study tests how common high BMI and periodontitis are among Thai adults aged 18–59 and what factors are linked to them.
-
New virtual care pathway for older adults with chronic diseases
A teleconsultation-based care pathway for adults 60+ with hypertension, diabetes, or dyslipidemia to see if it’s feasible and cost-saving in Malaysian primary care compared with usual clinic visits.
-
ECC4703 with Sulfasalazine and Pitavastatin in adults with NAFLD and dyslipidemia
This early study tests whether adding ECC4703 to sulfasalazine and pitavastatin is safe and how the body handles the combination in adults with fatty liver disease and high cholesterol.
-
Telehealth program for weight management and related health issues
This study is testing a new telehealth program for weight management to see if it helps obese adults with type 2 diabetes and liver issues lose weight and improve their health better than traditional in-person programs.
-
A registry for studying Non-Alcoholic Fatty Liver Disease in Europe
This study is collecting health information and samples from people with Non-Alcoholic Fatty Liver Disease to learn more about the disease and find better ways to track its progress.
Related topics
Quick answers
How many Dyslipidaemia clinical trials are recruiting right now?
5, as of November 12, 2026. 1 of them was first registered in the last 30 days. We update this list each time we refresh our data from ClinicalTrials.gov.
Where are these trials running?
In 16 countries. The most sites are in Singapore (1 trial), Malaysia (1 trial), Thailand (1 trial), Belgium (1 trial), Finland (1 trial). Each study page lists its sites and which ones are recruiting.
What phases are they in?
Phase 1: 1. Trials with no phase listed are usually device, behavioural or observational studies.
How do I join one?
Open a study, check the "Is this trial a fit for you?" section, then contact the study team listed on the page. They will ask a few screening questions. Asking is free and does not commit you to anything. Talk it over with your doctor first.
Find the studies that fit you
A list is a starting point. Tell us your situation in your own words and we'll rank the studies that match and explain why. It's free and needs no account.